Madison Brengle vs Sophia Biolay
Summary
Match Info
Analysis
Summary: No value: the market overprices Brengle relative to our conservative 63% win estimate, producing a negative EV at the current odds.
Highlights
- • Market-implied probability (82.4%) far exceeds our 63% estimate
- • Research shows symmetric career and recent form, offering no clear edge
Pros
- + Brengle is the market favorite and likely the safer match-level pick in raw probability terms
- + Short price means a win is likely, but not profitable at current odds
Cons
- - Price (1.214) implies a probability we cannot justify from the provided data
- - No surface, injury, or head-to-head evidence to support the heavy market edge
Details
We find no value on Madison Brengle at the available price. The market gives Brengle a very short price (1.214, implied ~82.4%) while the research shows both players with near-identical career profiles and recent form that does not clearly favor Brengle. With no visible injury edge, surface advantage, or head-to-head dominance in the provided data, we estimate Brengle's true win probability materially lower than the market-implied 82%. Using a conservative estimated true probability of 63%, the current home price is overpriced by the market and produces a negative expected value, so we do not recommend taking the favorite here.
Key factors
- • Market heavily favors Brengle (1.214 -> implied 82.4%)
- • Provided profiles show both players with nearly identical career records and recent losses
- • No injury, surface, or H2H evidence in the research to justify market's large gap